GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (XTER:4AB) » Definitions » Other Long Term Assets

AbbVie (XTER:4AB) Other Long Term Assets : €8,503 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is AbbVie Other Long Term Assets?

AbbVie's other long-term assets for the quarter that ended in Mar. 2025 was €8,503 Mil.

AbbVie's quarterly other long-term assets increased from Sep. 2024 (€7,467 Mil) to Dec. 2024 (€8,731 Mil) but then stayed the same from Dec. 2024 (€8,731 Mil) to Mar. 2025 (€8,503 Mil).

AbbVie's annual other long-term assets increased from Dec. 2022 (€5,259 Mil) to Dec. 2023 (€7,806 Mil) and increased from Dec. 2023 (€7,806 Mil) to Dec. 2024 (€8,731 Mil).

AbbVie Other Long Term Assets Historical Data

The historical data trend for AbbVie's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Other Long Term Assets Chart

AbbVie Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,987.52 4,322.34 5,259.02 7,806.42 8,730.61

AbbVie Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,341.64 8,544.01 7,467.49 8,730.61 8,502.60

AbbVie Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

AbbVie Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (XTER:4AB) » Definitions » Other Long Term Assets
Comparable Companies
JNJ MRK AMGN PFE GILD BMY BIIB OGN AMRN MDCX LLY OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276
Traded in Other Exchanges
ABBV:USA ABBV:Mexico 1ABBV:Italy 0QCV:UK ABBVCL:Chile ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria ABBV:Argentina
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
Website
https://www.abbvie.com
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines